Clinical and Regulatory Updates On Opioid Analgesics: An Evaluation of Best Practices and Stewardship

Tuesday, April 20, 2021, 4:00 PM - 7:30 PM

You will be able to describe the impact of the present opioid abuse epidemic during the time of COVID-19.  This activity will explore clinical and regulatory updates regarding opioid analgesics and will identify key regulation pharmacists should be aware of in dispensing opioid analgesics.

1. Describe the impact of the opioid abuse epidemic during the time of COVID-19.
2. Explore clinical and regulatory updates regarding opioid analgesics.
3. Identify key regulation pharmacists should be aware of in dispensing opioid analgesics.

Registration closes at promptly 9:00am on Sunday, April 18th.  There is no day-of registration:

General Registration Fee:  $45.00

For CPE credits:  In order to be eligible to claim CPE Law/Opioid 3.0 credits, you must include your NABP#, birth month/birth day in the "Profile" section, complete and pass the pre test and post test during this ce activity and complete the evaluation by end of day, April 20th 2021.

Zoom Meeting Link:  https://go.rutgers.edu/ksohpvui

 

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

ACPE Credits (3.00 hours)

The registration form for this activity is currently unavailable.

Tuesday, April 20, 2021

AcelRx Pharmaceuticals, Inc.  

https://pharmacy.rutgers.edu/clinical-and-regulatory-updates-on-opioid-analgesics-an-evaluation-of-best-practices-in-stewardship/